A detailed history of Mcdonald Partners LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Mcdonald Partners LLC holds 7,289 shares of BMY stock, worth $428,447. This represents 0.1% of its overall portfolio holdings.

Number of Shares
7,289
Previous 7,489 2.67%
Holding current value
$428,447
Previous $311,000 21.22%
% of portfolio
0.1%
Previous 0.09%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$39.66 - $51.75 $7,931 - $10,350
-200 Reduced 2.67%
7,289 $377,000
Q2 2024

Jul 17, 2024

SELL
$40.25 - $52.99 $1,891 - $2,490
-47 Reduced 0.62%
7,489 $311,000
Q1 2024

Apr 15, 2024

BUY
$47.98 - $54.4 $3,166 - $3,590
66 Added 0.88%
7,536 $408,000
Q4 2023

Feb 12, 2024

SELL
$48.48 - $57.85 $8,484 - $10,123
-175 Reduced 2.29%
7,470 $383,000
Q3 2023

Oct 30, 2023

BUY
$57.89 - $64.73 $83,361 - $93,211
1,440 Added 23.21%
7,645 $443,000
Q2 2023

Jul 17, 2023

SELL
$63.71 - $70.74 $9,429 - $10,469
-148 Reduced 2.33%
6,205 $396,000
Q1 2023

Apr 19, 2023

SELL
$65.71 - $74.53 $17,544 - $19,899
-267 Reduced 4.03%
6,353 $440,000
Q4 2022

Jan 18, 2023

BUY
$68.48 - $81.09 $753 - $891
11 Added 0.17%
6,620 $0
Q3 2022

Oct 21, 2022

SELL
$0.13 - $76.84 $533 - $315,044
-4,100 Reduced 38.29%
6,609 $470,000
Q2 2022

Jul 25, 2022

SELL
$72.62 - $79.98 $36,164 - $39,830
-498 Reduced 4.44%
10,709 $825,000
Q1 2022

Apr 29, 2022

BUY
$61.48 - $73.72 $686,547 - $823,231
11,167 Added 27917.5%
11,207 $818,000
Q4 2021

Jan 31, 2022

SELL
$53.63 - $62.52 $585,907 - $683,031
-10,925 Reduced 99.64%
40 $2,000
Q3 2021

Nov 24, 2021

SELL
$59.17 - $69.31 $29,585 - $34,655
-500 Reduced 4.36%
10,965 $649,000
Q3 2021

Oct 28, 2021

BUY
$59.17 - $69.31 $70,944 - $83,102
1,199 Added 11.68%
11,465 $678,000
Q2 2021

Nov 24, 2021

SELL
$61.91 - $67.42 $30,955 - $33,710
-500 Reduced 4.64%
10,266 $686,000
Q2 2021

Jul 23, 2021

BUY
$61.91 - $67.42 $34,174 - $37,215
552 Added 5.4%
10,766 $719,000
Q1 2021

Nov 24, 2021

SELL
$59.34 - $66.74 $32,637 - $36,707
-550 Reduced 5.11%
10,214 $645,000
Q1 2021

Apr 15, 2021

BUY
$59.34 - $66.74 $35,010 - $39,376
590 Added 5.8%
10,764 $680,000
Q4 2020

Feb 16, 2021

BUY
$57.74 - $65.43 $587,446 - $665,684
10,174 New
10,174 $631,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Mcdonald Partners LLC Portfolio

Follow Mcdonald Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcdonald Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mcdonald Partners LLC with notifications on news.